Kering Beauté aquires Creed
(Paris, France) June 26, 2023 – Kering Beauté has announced that it has signed an agreement to acquire 100% of Creed from funds controlled by BlackRock Long Term Private Capital Europe and current Chairman Javier Ferrán. Creed joins Kering Beauté’s portfolio of renowned luxury brands and provides Kering Beauté with…Read More
Read MoreHuman API Acquired by LexisNexis Risk Solutions
ATLANTA, April 25, 2023 /PRNewswire/ — LexisNexis® Risk Solutions, part of RELX, today announced it has acquired Human API, a leading provider of a proprietary consumer-driven data platform. LexisNexis Risk Solutions and Human API will deliver a next-generation consumer consent management solution that enables more seamless delivery of data. This approach empowers consumers…Read More
Read MoreSaluda Medical Announces $150M Equity Financing
Artarmon, NSW & Bloomington, MN – April 13, 2023 – Saluda Medical Inc. (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders, today announced the closing of a US $150…Read More
Read MoreLogicMark, Inc. Announces Closing of $5.2 Million Underwritten Public Offering Priced Above Market
LOUISVILLE, KY, Jan. 25, 2023 (GLOBE NEWSWIRE) – LogicMark, Inc. (Nasdaq: LGMK) (the “Company” or “LogicMark”), a provider of personal emergency response systems (PERS), health communications devices, and technology for the growing care economy, today announced the closing of its above market underwritten public offering. Gross proceeds, before deducting underwriting…Read More
Read MoreViatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences
PITTSBURGH – Jan. 3, 2023 – Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has closed its acquisitions of Oyster Point Pharma and Famy Life Sciences to establish a new Viatris Eye Care Division. The transaction was first announced on November 7 as part of Viatris’…Read More
Read More